Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Norris Medicines Ltd has submitted a routine quarterly compliance certificate to BSE for the quarter ended 30th June 2025. The certificate, issued by the company's Registrar and Transfer Agent Purva Sharegistry (India) Private Limited, confirms that share certificates received from depository participants for dematerialization during the quarter were properly processed, accepted or rejected, and the relevant entries were updated in the register of members within prescribed timelines. Around 21 shareholders converted approximately 2,220 physical shares into demat form during April–June 2025, with the largest single conversion being 450 shares by Vijay K Gavde. The filing was signed by Director Praveenchand Bafna (DIN: 06538685) on 18th July 2025.
This is a standard regulatory compliance filing with no bearing on business operations, financials, or shareholder value. It merely confirms routine share dematerialization activity — no action needed from investors.